Hormonal
replacement therapy is a type of treatment wherein patients receive a course of hormones in
order to get relieve from the menopause related problems. The therapy involves
administration of synthetic estrogen and progesterone to overcome decreasing
hormone level of women.
Access
More About This Research at:
The most
common signs and symptoms observed in patients with decreased hormone level are
irregular menstrual cycles, and psychological symptoms (mood swings, anxiety,
and urogenital symptoms). Venous thromboembolism, stroke, breast cancer, Alzheimer’s
disease and gall bladder related disorders are some of the major adverse
effects of hormonal replacement therapeutics.
Request
to Get the Sample Pages at:
Evestra Inc.
is developing EC508 hormone replacement therapy for fertility related problems.
Novo Nordisk A/S is another key player involved in development of hormone
replacement therapy.
The report
provides a comprehensive understanding of the pipeline activities covering all
drug candidates under various stages of development, with the detailed analysis
of pipeline and clinical trials.
Pipeline
analysis of drugs by phases includes product description and development
activities including information about clinical results, designations,
collaborations, licensing, grants, technology, and others.
